ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Holland, Leader Win $250,00 Milken Awards: Six Others Get $50,000 Prizes

December 9, 1988

Breast Density Does Not Raise Breast Cancer Death Rates

August 31, 2012

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

January 20, 1989

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

Agencies Announce Plans To Monitor Gene Therapy Trials.

March 10, 2000

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007